An Exceedingly Rare Case of Liraglutide-Induced Liver Injury.

Swetha Parvataneni Rajarajeshwari Ramachandran Eric Omar Then Tyler Grantham Vinaya Gaduputi

Published in: Case reports in gastrointestinal medicine (2021)

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug.

Keyphrases

liver injury
drug induced
rare case
adverse drug
emergency department
combination therapy